Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Kymera Therapeutics, Inc. (NASDAQ: KYMR)
KYMR Stock Predictions and Ratings
WSX Rating:
STRONG SELL
WSX Forecast (1yr):
-68%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
54%
KYMR Stock Analysis
KYMR
PE Ratio:
KYMR
PEG Ratio:
Not Available
KYMR
Forward EPS Growth (12 month):
0.00%
KYMR
PS Ratio:
117
KYMR
PSG Ratio:
-2
KYMR
Forward Revenue Growth (12 month):
-57.30%
KYMR Articles
No data was found